Sarah Cannon/FCSRI is a clinical research site located in Fort Myers, Florida, United States 33908.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon/FCSRI has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma.
Sponsors: Ascentage Pharma Group Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon/FCSRI has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon/FCSRI has 1 clinical trials on record, with 1 currently active. Their work covers Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma.
Sarah Cannon/FCSRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.